We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

RMTI Rockwell Medical Inc

0.055 (3.08%)
Dec 01 2023 - Closed
Delayed by 15 minutes


Draw Mode:

Volume 252,226
Bid Price 1.77
Ask Price 1.88
News -
Day High 1.87


52 Week Range


Day Low 1.785
Company Name Stock Ticker Symbol Market Type
Rockwell Medical Inc RMTI NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.055 3.08% 1.84 20:00:00
Open Price Low Price High Price Close Price Prev Close
1.80 1.785 1.87 1.84 1.785
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
2,061 252,226 $ 1.83 $ 461,154 - 0.942 - 6.24
Last Trade Time Type Quantity Stock Price Currency
16:00:24 68 $ 1.83 USD

Rockwell Medical Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
51.85M 28.49M - 72.81M -18.68M -0.66 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Rockwell Medical News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No RMTI Message Board. Create One! See More Posts on RMTI Message Board See More Message Board Posts

Historical RMTI Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.901.9611.781.86131,782-0.06-3.16%
1 Month1.992.281.781.98233,246-0.15-7.54%
3 Months2.112.481.532.00268,882-0.27-12.8%
6 Months3.746.241.533.73752,784-1.90-50.8%
1 Year1.026.240.9423.36484,1260.8280.39%
3 Years1.,5520.7670.37%
5 Years3.316.880.201.69784,973-1.47-44.41%

Rockwell Medical Description

Rockwell Medical Inc is a US-based fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease with its products and services for the treatment of iron deficiency, and hemodialysis. The company's drug products are Triferic. Triferic is a therapy indicated to replace iron and maintain hemoglobin in adult hemodialysis patients with chronic kidney disease. The company operates in one segment of the hemodialysis market which involves the exports, manufacture, sale, and distribution of hemodialysis products. Key revenue is generated from the United States.

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 |